Literature DB >> 20737202

Profile of autoantibodies against phosphorylcholine and cross-reactivity to oxidation-specific neoantigens in selective IgA deficiency with or without autoimmune diseases.

Ana Elisa Fusaro1, Kristine Fahl, Elaine Cristina Cardoso, Cyro Alves de Brito, Cristina M A Jacob, Magda Carneiro-Sampaio, Alberto J S Duarte, Maria Notomi Sato.   

Abstract

Immunoglobulin A deficiency (IgAD) is considered the most common form of primary immunodeficiency. The majority of IgA-deficient individuals are considered asymptomatic, even though IgAD has been associated with an increased frequency of recurrent infections, allergy, and autoimmune diseases. In this study we evaluate the Natural autoantibodies (NatAbs) reactivity to phosphorylcholine (PC) and to some pro-inflammatory molecules in IgAD with or without autoimmune disorders. We observed that in the absence of IgA there is an enhancement of IgG subclasses functioning as NatAbs against PC. Immunoglobulin G (IgG) against lipopolysaccharide, C-reactive protein, and IgA was found in IgAD, regardless of the autoimmune manifestations. Nonetheless, IgAD patients with autoimmune disease showed significantly higher IgG reactivity against pro-inflammatory molecules, such as cardiolipin, oxidized low-density lipoproteins, and phosphatidylserine, with positive correlation between them. In conclusion, the IgG NatAbs against PC may represent a compensatory defense mechanism against infections and control excess of inflammation, explaining the asymptomatic status in the IgA deficiency.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20737202     DOI: 10.1007/s10875-010-9453-y

Source DB:  PubMed          Journal:  J Clin Immunol        ISSN: 0271-9142            Impact factor:   8.317


  43 in total

1.  Progression of selective IgA deficiency to common variable immunodeficiency.

Authors:  Asghar Aghamohammadi; Javad Mohammadi; Nima Parvaneh; Nima Rezaei; Mostafa Moin; Teresa Espanol; Lennart Hammarstrom
Journal:  Int Arch Allergy Immunol       Date:  2008-06-03       Impact factor: 2.749

2.  Antibodies of IgM subclass to phosphorylcholine and oxidized LDL are protective factors for atherosclerosis in patients with hypertension.

Authors:  Jun Su; Anastasia Georgiades; Ruihua Wu; Thomas Thulin; Ulf de Faire; Johan Frostegård
Journal:  Atherosclerosis       Date:  2005-11-22       Impact factor: 5.162

3.  Anaphylactoid transfusion reactions associated with anti-IgA.

Authors:  G N Vyas; H A Perkins; H H Fudenberg
Journal:  Lancet       Date:  1968-08-10       Impact factor: 79.321

Review 4.  Autoimmunity in human primary immunodeficiency diseases.

Authors:  Peter D Arkwright; Mario Abinun; Andrew J Cant
Journal:  Blood       Date:  2002-04-15       Impact factor: 22.113

5.  Variable increases of IgG and IgM antibodies in milk of IgA deficient women.

Authors:  M Hahn-Zoric; B Carlsson; J Björkander; L Mellander; V Friman; L Padyukov; L A Hanson
Journal:  Pediatr Allergy Immunol       Date:  1997-08       Impact factor: 6.377

6.  Selective IgA deficiency in children and adults with systemic lupus erythematosus.

Authors:  J T Cassidy; R K Kitson; C L Selby
Journal:  Lupus       Date:  2007       Impact factor: 2.911

7.  Phosphorylcholine: friend or foe of the immune system?

Authors:  W Harnett; M M Harnett
Journal:  Immunol Today       Date:  1999-03

8.  Cross-reactive antibodies induced by xenogeneic IgA can cause selective IgA deficiency.

Authors:  Ayelet Klartag; Chiann-Chyi Chen; Joseph P Dougherty; Yacov Ron
Journal:  Autoimmunity       Date:  2010-03       Impact factor: 2.815

9.  Cross-reactivity of anti-phosphorylcholine antibodies to neuromuscular blockers in a murine model of immunization.

Authors:  Rosa Maria Mazzuco; Maria Notomi Sato; Dewton de Moraes Vasconcelos; Alberto José da Silva Duarte
Journal:  Int Immunopharmacol       Date:  2007-05-24       Impact factor: 4.932

10.  The shared CTLA4-ICOS risk locus in celiac disease, IgA deficiency and common variable immunodeficiency.

Authors:  K Haimila; E Einarsdottir; A de Kauwe; L L E Koskinen; Q Pan-Hammarström; T Kaartinen; K Kurppa; F Ziberna; T Not; S Vatta; A Ventura; I R Korponay-Szabo; R Adány; Z Pocsai; G Széles; E Dukes; K Kaukinen; M Mäki; S Koskinen; J Partanen; L Hammarström; P Saavalainen
Journal:  Genes Immun       Date:  2008-11-20       Impact factor: 2.676

View more
  4 in total

Review 1.  Microbial modulation of host immunity with the small molecule phosphorylcholine.

Authors:  Sarah E Clark; Jeffrey N Weiser
Journal:  Infect Immun       Date:  2012-12-10       Impact factor: 3.441

2.  Pathogenic natural antibodies propagate cerebral injury following ischemic stroke in mice.

Authors:  Andrew Elvington; Carl Atkinson; Liudmila Kulik; Hong Zhu; Jin Yu; Mark S Kindy; V Michael Holers; Stephen Tomlinson
Journal:  J Immunol       Date:  2011-12-23       Impact factor: 5.422

3.  Selective IgA deficiency: clinical and laboratory features of 118 children in Turkey.

Authors:  Caner Aytekin; Nilden Tuygun; Selim Gokce; Figen Dogu; Aydan Ikinciogullari
Journal:  J Clin Immunol       Date:  2012-05-01       Impact factor: 8.317

4.  Lipid anti-lipid antibody responses correlate with disease activity in systemic lupus erythematosus.

Authors:  Vojislav Jovanović; Nurhuda Abdul Aziz; Yan Ting Lim; Amanda Ng Ai Poh; Sherlynn Jin Hui Chan; Eliza Ho Xin Pei; Fei Chuin Lew; Guanghou Shui; Andrew M Jenner; Li Bowen; Eoin F McKinney; Paul A Lyons; Michael D Kemeny; Kenneth G C Smith; Markus R Wenk; Paul A Macary
Journal:  PLoS One       Date:  2013-02-07       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.